AP Biosciences, Inc. (TPEX:6945)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
186.50
0.00 (0.00%)
Apr 29, 2026, 2:00 PM CST

AP Biosciences Revenue

Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
37
Market Cap
15.96B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 202332.25M--
Dec 31, 2022---
Dec 31, 20216.99M-130.57M-94.92%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Locus Cell 12.74M
Medigen Vaccine Biologics 613.17M
Polaris Group 40.60M
EirGenix 1.01B
TaiMed Biologics 611.35M
Lumosa Therapeutics 35.83M
Sunmax Biotechnology 2.03B
CHO Pharma 1.43M
Revenue Rankings